Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile
Todd M. Sachs, MD

@toddsachsmd

Physician, Surgeon, and Chief Medical Officer at @myaccesshope, a subsidiary of @cityofhope. These thoughts and opinions are my own and not medical advice.

ID: 859152644597727232

linkhttps://www.myaccesshope.org/ calendar_today01-05-2017 21:08:47

256 Tweet

1,1K Takipçi

640 Takip Edilen

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

By democratizing expertise, AccessHope is leveling disparities and extending support—to give more people an equal chance at better outcomes. On this #WorldCancerDay, see how we’re doing our part to #CloseTheCareGap in our blog post.

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Thank you, Collective Health Health, for the opportunity to discuss how cancer support will evolve this year. AccessHope remains focused on helping more people access subspecialty expertise, regardless of their ZIP code.

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

84% of people who have received a cancer diagnosis don’t seek a second opinion, but a second review by NCI-level experts changed the diagnosis for 43% of patients (National Library of Medicine). Learn how in the AccessHope blog post below. hubs.la/Q015crtG0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Advancements in precision medicine have tremendously helped oncologists find the most-suitable treatments for people with cancer. The AccessHope blog post below highlights the basics on this innovative approach to cancer care. hubs.la/Q015nbGS0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

The initial treatment of patients with AML at NCI–Designated Cancer Centers is associated with a 53% reduction in early mortality (National Library of Medicine) compared to treatment at non–NCI-level Cancer Centers. Learn why NCI-level expertise is important. hubs.la/Q015nSHV0

The initial treatment of patients with AML at NCI–Designated Cancer Centers is associated with a 53% reduction in early mortality (<a href="/NLM_NIH/">National Library of Medicine</a>) compared to treatment at non–NCI-level Cancer Centers. Learn why NCI-level expertise is important. hubs.la/Q015nSHV0
Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Due to the aggressive nature of liver cancer, the majority of patients are often diagnosed at a late stage—when surgery may not be an option. However, new targeted treatments are leading the way to treatment options for these cancers. hubs.la/Q015nQcT0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

New findings from NIH Library researchers found that the percentage of American women overdue for a cervical cancer screening grew from 14% in 2005 to 23% in 2019. Make sure to check with your doctor as it’s important to detect any potential precancerous changes as early as possible.

New findings from <a href="/nihlib/">NIH Library</a> researchers found that the percentage of American women overdue for a cervical cancer screening grew from 14% in 2005 to 23% in 2019. Make sure to check with your doctor as it’s important to detect any potential precancerous changes as early as possible.
Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

According to @americancancer, doctors will diagnose around 237,000 new lung cancer cases in the United States in 2022. If you have a history of smoking, speak with your doctor about proper screening in order to identify and treat any potential malignancy.

According to @americancancer, doctors will diagnose around 237,000 new lung cancer cases in the United States in 2022. If you have a history of smoking, speak with your doctor about proper screening in order to identify and treat any potential malignancy.
Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Thank you, Collective Health, for the opportunity to share how employer-sponsored benefit programs like AccessHope can help make healthcare more inclusive.

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

An article from National Cancer Institute highlights how remote cancer support services can reshape a patient’s cancer journey -- they can help save time and resources, protect weakened immune systems, and achieve the best outcomes possible. hubs.la/Q01btKzx0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

I am looking forward to speaking in an upcoming Employee Benefit News webinar 8/16 at 10:30 am PT. Health disparities can impact treatment outcomes, and employers can help employees with cancer get remote access to the latest knowledge and expertise they deserve, regardless of location

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

We’re excited to share that Fred Hutchinson Cancer Center has joined our unique collaboration of NCI–Designated Comprehensive Cancer Centers!

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

The holidays can feel very different when you or a loved one has cancer. Here is some insight on how to navigate a cancer journey during the holidays in this article from our AccessHope foundational partner, Dana-Farber hubs.la/Q01wjw4T0

The holidays can feel very different when you or a loved one has cancer. 
Here is some insight on how to navigate a cancer journey during the holidays in this article from our AccessHope foundational partner, <a href="/DanaFarber/">Dana-Farber</a>

hubs.la/Q01wjw4T0
Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Per Business Group on Health's 2023 Survey, cancer is the top driver of large companies’ healthcare costs. See how AccessHope is aiding employees facing cancer and their oncologists to help ensure they’re on the right path as early as possible: hubs.la/Q01BqS760

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Can telehealth-based interventions address three behavioral risk factors all at once to modify cancer patients' lifestyles and improve outcomes? Learn more in this article about Northwestern’s first-of-its-kind cancer care initiative. hubs.la/Q01Br5vB0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

The rising rate of young adults diagnosed with colorectal cancer stresses the importance of prevention and early detection. City of Hope announced they may have developed a new blood test that can detect early-onset colorectal cancer. Read more at hubs.la/Q01BqQ9D0

Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

Cancer isn’t one disease. #PrecisionMedicine enables oncologists to match treatments to specific cancers, leading to the best possible outcomes while minimizing side effects and overtreatment. Read more: hubs.la/Q01Br02G0

AccessHope (@myaccesshope) 's Twitter Profile Photo

We’re thrilled to announce the addition of Johns Hopkins Medicine to our network of NCI-Designated Comprehensive Cancer Centers. This collaboration will increase access to insights on cancer expertise, treatment, and research for individuals across the US. hubs.la/Q022CvQp0

We’re thrilled to announce the addition of <a href="/HopkinsMedicine/">Johns Hopkins Medicine</a> to our network of NCI-Designated Comprehensive Cancer Centers. This collaboration will increase access to insights on cancer expertise, treatment, and research for individuals across the US. 

hubs.la/Q022CvQp0
Todd M. Sachs, MD (@toddsachsmd) 's Twitter Profile Photo

I am looking forward to joining my fellow thought leaders as we meet at the intersection of virtual care and oncology. We will explore its potential and how it is addressing challenges in oncology head-on in this insightful webinar. See you online!

AccessHope (@myaccesshope) 's Twitter Profile Photo

We are thrilled to announce the addition of UT Southwestern Medical Center – our seventh foundational partner – to AccessHope’s elite network of National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers. AccessHope’s employer plan members and their treating oncologists in Texas,

We are thrilled to announce the addition of <a href="/UTSWMedCenter/">UT Southwestern Medical Center</a>   – our seventh foundational partner – to AccessHope’s elite network of National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers. AccessHope’s employer plan members and their treating oncologists in Texas,